Key Points
In the backdrop of a caution by the Indian Pharmacopoeia Commission (IPC) against mefenamic acid, a major component of painkiller meftal, the medicine's manufacturer on Tuesday said the alert seeks to advise doctors and patients to monitor the possibility of an adverse reaction of the drug...
"The alert issued by IPC was to advise doctors and patients to monitor the possibility of an adverse drug reaction of mefenamic acid, which does not in any way impact the safety, efficacy and high quality of the brands that are established and supported by clinical studies," Blue Cross Laboratories, which makes meftal and meftal-spas, said in a statement...
The IPC on November 30 had issued an alert on mefenamic acid stating that a preliminary analysis of adverse drug reactions from the Pharmacovigilance Programme of India (PvPI) database revealed drug reactions with eosinophilia and systemic symptoms (DRESS) syndrome...
You might be interested in
Govt body issues safety alert for common period painkiller — what you need to know
08, Dec, 23Mefenamic acid, sold under various brand names such as Meftal, Mefanorm, and Mefkind, can cause DRESS Syndrome, a rare but serious condition that can damage the liver, heart, and lungs.
Government issues alert against adverse reactions of painkiller Meftal
07, Dec, 23The painkiller is commonly used for menstrual cramps and rheumatoid arthritis. The Indian Pharmacopoeia Commission (IPC) has issued a drug safety alert advising h